Immediate Impact
66 standout
Citing Papers
Glomerulonephritis: immunopathogenesis and immunotherapy
2023 Standout
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
2023 Standout
Works of Junichiro Mera being referenced
Clinicopathologic Study on Prognostic Markers in IgA Nephropathy
2000
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Junichiro Mera | 43 | 189 | 6 | 190 | 63 | 7 | 311 | |
| Almudena Martín‐Peña | 9 | 107 | 4 | 188 | 66 | 11 | 274 | |
| M.C. Ethier | 21 | 77 | 2 | 129 | 158 | 8 | 355 | |
| Lauren Strazzula | 53 | 107 | 3 | 72 | 63 | 13 | 350 | |
| Craig S. Rosenfeld | 11 | 264 | 219 | 171 | 9 | 355 | ||
| Gary Gartenberg | 14 | 141 | 2 | 118 | 20 | 11 | 269 | |
| Stacey A. Henning | 8 | 139 | 1 | 126 | 85 | 9 | 287 | |
| D. BenEzra | 25 | 109 | 3 | 159 | 32 | 5 | 334 | |
| C. Karl | 6 | 286 | 5 | 223 | 59 | 4 | 333 | |
| Chiara Rosin | 6 | 254 | 3 | 174 | 29 | 8 | 322 | |
| Anthony I. Sahyoun | 25 | 92 | 4 | 101 | 32 | 12 | 321 |
All Works
Loading papers...